The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
yellow fever virus strain 17d-204 live antigen
2 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Live Attenuated Yellow Fever Virus Vaccine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Yellow fever virus strain 17d-204 live antigen in shortage right now?
- No. FDA does not currently list Yellow fever virus strain 17d-204 live antigen in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Yellow fever virus strain 17d-204 live antigen?
- 1 company has marketed Yellow fever virus strain 17d-204 live antigen in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.